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The ﬁ rst anniversary of the west African Ebola 
epidemic has just passed. In Guinea, Liberia, and Sierra 
Leone, Ebola virus disease has resulted in more than 
10 000 reported deaths while the virtual collapse of 
the countries’ health-care systems has contributed to 
countless more. In The Lancet Infectious Diseases, Patrick 
Walker and colleagues1 describe a mathematical model 
to estimate the eﬀ ect of the ongoing Ebola disease 
epidemic on a less exotic and more familiar killer—
malaria. The estimates are sobering, if not surprising: 
up to 10 900 additional malaria deaths in these three 
countries in 2014 can be attributed to the disruption 
of health-care services, with another 3900 attributed 
to lapses in the delivery of insecticide-treated bednets. 
The investigators predicted continued excess malaria 
mortality in 2015 and a rise in malaria transmission if 
immediate emergency strategies to control malaria are 
not implemented.
During the past decade, renewed commitment from 
donors, ministries of health, and international agencies 
has led to the scale-up of malaria interventions across 
sub-Saharan Africa, with a corresponding reduction in 
child malaria mortality of 50%.2 The continuous delivery 
of those life-saving interventions—prompt eﬀ ective 
treatment, routine distribution of insecticide-treated 
bednets, indoor residual spraying, and intermittent 
preventive treatment of malaria in pregnancy—depends 
on a reliable, functioning health-care system. Large-scale 
challenges to already fragile health-care systems, as has 
occurred with Ebola virus disease, can result in disruption 
of programmes, which in turn could threaten or reverse 
the gains achieved in malaria control. Walker and 
colleagues have shown how quickly and extensively that 
reversal can occur.
Although many countries in Africa have had major 
success in the reduction of malaria, many west 
African countries continue to suﬀ er a comparatively 
high malaria burden. The 2014 World Malaria Report 
documents that seven of the ten highest malaria 
parasite prevalences are in west African countries.2 
Political strife and conﬂ ict have further impaired health 
and health-care development in the three countries 
aﬀ ected by Ebola virus disease. Renewed attention 
and resources are urgently needed to scale-up malaria 
interventions in these countries. 
Walker and colleagues model the eﬀ ect of two 
interventions designed to reduce malaria fevers, 
illness, and deaths: monthly mass antimalarial drug 
administration, and a mass insecticide-treated bednet 
distribution campaign. The beneﬁ t of these measures 
is predicted to be substantial.1 However, these 
intervention campaigns are costly, both ﬁ nancially and 
in material and human resources—particularly when 
deployed during an emergency response such as for 
Ebola virus disease when capacity might be focused on 
Ebola response activities. Additionally, the campaigns 
could introduce a risk of exposure to Ebola virus for 
people delivering the interventions in the community 
and for those presenting to a distribution site to receive 
the interventions. But few eﬀ ective alternatives are 
available to reduce malaria morbidity in low-functioning 
health-care systems. There are numerous examples 
of successful mass bednet distribution campaigns, 
but experience with mass drug administration has 
been more limited. An eﬀ ort in Sierra Leone resulted 
in successful mass drug administration for more than 
2 million people.3 Until service delivery systems are 
restored, these extraordinary measures, delivered after 
careful planning and with due attention to safety, are 
warranted. 
Because quality routine surveillance data are not 
available, it is primarily through modelling that the 
broader indirect health eﬀ ects of the Ebola epidemic 
(in this case malaria) can be understood. However, 
models cannot replace high quality surveillance data. 
The establishment and maintenance of accurate, timely 
disease surveillance systems is essential to obtain real-
time actionable information to assess eﬀ ects, provide 
alerts, and direct programme resources.4     
During the past year, the consequence of the global 
communities’ lack of investment in health-care systems 
in west Africa has become strikingly evident. We have an 
opportunity to address this shortcoming now, with the 
recent multinational commitment to the Global Health 
Security Agenda.4 The agenda has ambitious objectives, 
including support to strengthen real-time surveillance 
systems and to train and deploy an eﬀ ective disease 
surveillance workforce. If implemented well, health-care 
systems will be strengthened so that the next global 
health threat will be detected, reported, and contained 
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quickly. But just as importantly, these systems should 
also accurately measure and report on ﬂ uctuations in 
serious established diseases, including malaria, to enable 
an eﬀ ective programmatic response.
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An outbreak of urogenital schisto somiasis has been 
detected in Europe, with patients aﬀ ected in France,1,2 
Germany,1,2 and Italy. The infection originated in 
Corsica, in a river north of Porto-Vecchio, a popular 
tourist destination (ﬁ gure). The introduction of 
schistosomiasis is believed to be associated with 
infected people arriving from a region endemic for the 
exclusively African parasite, Schistosoma haematobium 
and disseminating parasite eggs through their urine 
into snail breeding sites along the river. Subsequent 
infection of freshwater planorbid snails, Bulinus 
truncatus, which are present throughout Corsica,3 then 
occurred, showing the compatibility of the imported 
parasite with the local snail.
Transmission seems to have occurred since 2011. The 
late dis covery of this situation in May, 2014, was related 
to misdiagnosis of haematuria in patients infected in 
previous years who had never been to Africa and thus 
the absence of trips to Africa being listed in their case 
histories. This outbreak is unexpected; the last recorded 
case of S haematobium transmission in Europe was in 
southern Portugal where the ﬁ nal patient was cured 
in 1967. Urogenital schistosomiasis was then declared 
eliminated in Europe and not viewed as an infection that 
presented a risk of introduction into the continent.
This outbreak raises several questions. Did people who 
were initially infected return and urinate in the same 
river every year, con tributing to the maintenance of the 
focus? Analyses suggest that both tourists and local 
residents have become infected. Has climate change in 
southern Europe allowed an over wintering transmission 
to proceed uninterrupted in recent years? Will changes 
in temperature and rainfall in the Mediterranean aﬀ ect 
freshwater snail-borne diseases?4 Snail-borne infections 
have not been considered in a survey mapping climate 
change vulnerabilities to infectious diseases in Europe.5
Molecular studies on the Corsican schistosome strain 
have shown that, in addition to pure S haematobium, 
most of the eggs collected from patients are hybrids of 
S haematobium and the livestock species Schistosoma 
bovis. This unexpected ﬁ nding sug gests that either 
several intro ductions from human beings infec ted with 
the diﬀ erent strains of S haematobium occurred, or that 
hybridisation has occurred in Corsica. Furthermore, 
the involvement of such a hybrid form has many 
repercussions. It increases the range of potential vectors, 
since the widespread Planorbarius metidjensis snail 
transmits S bovis, thus increasing the risk of dis semination 
to Portugal, Spain, and Italy.
Schistosomiasis reaches Europe
Figure: Focus of freshwater transmission of urogenital schistosomiasis frequented by tourists in Corsica 
This river is visited by 3000–5000 people every day during the summer season.
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